Zymeworks Presents Safety And Anti-Tumor Activity Data From The Ongoing Phase I Study Of ZW25 At ASCO Annual Meeting (ASCO 2017) - BioLegacy Research

Zymeworks Presents Safety And Anti-Tumor Activity Data From The Ongoing Phase I Study Of ZW25 At ASCO Annual Meeting (ASCO 2017)

Post author:Sam
Post published:June 4, 2017
Post category:BioPharma

Life Sciences Jobs …
Source: BioSpace